secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bicara Therapeutics Inc. (BCAX)
CIK:        0002023658
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001193125-26-076560
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicara raises $161.8M in public offering; reports preliminary cash of $414.8M
-----------------------------------------------------------------------------

- Net proceeds of ~$161.8M from offering of 7.175M shares at $16.00/sh and 2.2M pre-funded warrants.
- Preliminary unaudited cash, cash equivalents and investments as of Dec 31, 2025: ~$414.8M.
- Proceeds to support commercial infrastructure for ficerafusp alfa, accelerated development, and manufacturing.
- Underwriters exercised option for additional 1,406,250 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023658/000119312526076560/0001193125-26-076560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023658/000119312526076560/d938194d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-076560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer